摘要
双功能酶AAC(6′)-APH(2″)是一种重要的氨基糖苷类抗生素钝化酶,从临床分离出的6株耐甲氧西林金黄色葡萄球菌(MRSA)的总DNA中克隆得到AAC(6′)-APH(2″)基因,将该基因插入质粒pET-28a中构建表达载体,然后将该重组质粒转入大肠杆菌BL21进行异源表达,在IPTG的诱导下产生大量可溶性目标重组蛋白,该重组蛋白经亲和层析分离纯化,SDS-PAGE鉴定纯度大于90%;建立了此双功能酶的体外测活方法,为建立氨基糖苷类抗生素双功能酶抑制剂筛选模型奠定基础.
Bifunction enzyme AAC(6′)-APH(2″) is an important passivation enzyme of aminoglycosides(AGs).The chromosome gene encoding AG bifunctional enzyme from the 6 MRSA clinical isolates was cloned and introduced into expression plasmid pET-28a,and then was transformed into E.coli BL21(DE3).The strains produced large amounts of soluble recombinant protein under IPTG induction.The protein was purified by affinity chromatography.After purification,the purity of recombinant AAC(6′)-APH(2″) reached 90%.A method to assay the recombinant enzyme activity was developed in vitro,which laid a good basis for developing a screening model for obtaining the AAC(6′)-APH(2″) inhibitors.
出处
《上海师范大学学报(自然科学版)》
2011年第3期301-305,共5页
Journal of Shanghai Normal University(Natural Sciences)
基金
国家自然科学基金项目(30801449)
国家"重大新药创制"科技重大专项项目(2009ZX09301-007)
上海市自然科学基金项目(09ZR1430800)